Renal Cell Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial
Condition: Advanced Renal Cell Carcinoma Interventions: Drug: Botensilimab; Drug: Balstilimab; Drug: Ipilimumab; Drug: Nivolumab Sponsors: Michael B. Atkins, MD; Agenus Inc.; Georgetown University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma
Condition: Renal Cell Carcinoma Intervention: Diagnostic Test: 68Ga-NY104 PET/CT Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials
